Biotechnology: an opportunity balanced on a knife’s edge

To fully harness the benefits of a thriving biotechnology industry, it is critical we act to address the challenges that threaten it.
We are observing an exodus of talent from our country towards greener pastures, and limited growth in a field of incredible strategic interest, writes Adam Damry.

With the COVID-19 pandemic fresh in our memories, the impact of biotechnology has never been as apparent with the swift deployment and development of lifesaving mRNA vaccines showcasing the capacity of this field to contribute to global solutions. Continuing breakthroughs in...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES